SE0301904D0 - Novel imidazopyridine compound II with therapeutic effect - Google Patents

Novel imidazopyridine compound II with therapeutic effect

Info

Publication number
SE0301904D0
SE0301904D0 SE0301904A SE0301904A SE0301904D0 SE 0301904 D0 SE0301904 D0 SE 0301904D0 SE 0301904 A SE0301904 A SE 0301904A SE 0301904 A SE0301904 A SE 0301904A SE 0301904 D0 SE0301904 D0 SE 0301904D0
Authority
SE
Sweden
Prior art keywords
compound
therapeutic effect
therapeutically acceptable
relates
imidazopyridine compound
Prior art date
Application number
SE0301904A
Other languages
English (en)
Inventor
Peter Nordberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301904A priority Critical patent/SE0301904D0/sv
Publication of SE0301904D0 publication Critical patent/SE0301904D0/sv
Priority to TW093117866A priority patent/TW200503702A/zh
Priority to ARP040102166A priority patent/AR044855A1/es
Priority to KR1020057024661A priority patent/KR20060030479A/ko
Priority to AU2004249655A priority patent/AU2004249655B2/en
Priority to BRPI0411728-0A priority patent/BRPI0411728A/pt
Priority to EP04749051A priority patent/EP1641793B1/en
Priority to JP2006517052A priority patent/JP4701168B2/ja
Priority to DE602004011773T priority patent/DE602004011773T2/de
Priority to AT04749051T priority patent/ATE386033T1/de
Priority to PCT/SE2004/001013 priority patent/WO2004113339A1/en
Priority to SI200430638T priority patent/SI1641793T1/sl
Priority to MXPA05013643A priority patent/MXPA05013643A/es
Priority to ES04749051T priority patent/ES2300796T3/es
Priority to UAA200511721A priority patent/UA81953C2/uk
Priority to CNA2004800175782A priority patent/CN1809567A/zh
Priority to PT04749051T priority patent/PT1641793E/pt
Priority to DK04749051T priority patent/DK1641793T3/da
Priority to PL04749051T priority patent/PL1641793T3/pl
Priority to RU2005141059/04A priority patent/RU2348634C2/ru
Priority to CN2010102568618A priority patent/CN101941968A/zh
Priority to CA002530181A priority patent/CA2530181A1/en
Priority to US10/561,199 priority patent/US7691875B2/en
Priority to MYPI20042466A priority patent/MY140718A/en
Priority to UY28384A priority patent/UY28384A1/es
Priority to IL172530A priority patent/IL172530A0/en
Priority to ZA200510455A priority patent/ZA200510455B/en
Priority to IS8258A priority patent/IS8258A/is
Priority to NO20060425A priority patent/NO20060425L/no
Priority to HK06108623A priority patent/HK1088315A1/xx
Priority to HR20080179T priority patent/HRP20080179T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE0301904A 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect SE0301904D0 (sv)

Priority Applications (31)

Application Number Priority Date Filing Date Title
SE0301904A SE0301904D0 (sv) 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect
TW093117866A TW200503702A (en) 2003-06-26 2004-06-21 Novel imidazopyridine compound ii with therapeutic effect
ARP040102166A AR044855A1 (es) 2003-06-26 2004-06-22 Compuesto de imidazopiridina
US10/561,199 US7691875B2 (en) 2003-06-26 2004-06-23 Imidazopyridine compounds, processes for their preparation and therapeutic uses thereof
UAA200511721A UA81953C2 (uk) 2003-06-26 2004-06-23 Сполука імідазопіридину іі з терапевтичною дією
PT04749051T PT1641793E (pt) 2003-06-26 2004-06-23 Novo composto de imidazopiridina ii com efeito terapêutico
BRPI0411728-0A BRPI0411728A (pt) 2003-06-26 2004-06-23 composto, processo a preparação de um composto, formulação farmacêutica, uso de um composto, e, método de tratamento e/ ou inibição de doenças
EP04749051A EP1641793B1 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound ii with therapeutic effect
JP2006517052A JP4701168B2 (ja) 2003-06-26 2004-06-23 治療効果を有する新規なイミダゾピリジン化合物ｉｉ
DE602004011773T DE602004011773T2 (de) 2003-06-26 2004-06-23 Neue imidazopyridinverbindung ii mit therapeutischer wirkung
AT04749051T ATE386033T1 (de) 2003-06-26 2004-06-23 Neue imidazopyridinverbindung ii mit therapeutischer wirkung
PCT/SE2004/001013 WO2004113339A1 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound ii with therapeutic effect
SI200430638T SI1641793T1 (sl) 2003-06-26 2004-06-23 Nova imidazopiridinska spojina II s terapevtskim učinkom
MXPA05013643A MXPA05013643A (es) 2003-06-26 2004-06-23 Nuevo compuesto de imidazopiridina ii con efecto terapeutico.
ES04749051T ES2300796T3 (es) 2003-06-26 2004-06-23 Nuevo compuesto de imidazopiridina ii con efecto terapeutico.
KR1020057024661A KR20060030479A (ko) 2003-06-26 2004-06-23 치료 효과를 갖는 신규 이미다조피리딘 화합물 ｉｉ
CNA2004800175782A CN1809567A (zh) 2003-06-26 2004-06-23 具有治疗效果的新咪唑并吡啶化合物ⅱ
AU2004249655A AU2004249655B2 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound ii with therapeutic effect
DK04749051T DK1641793T3 (da) 2003-06-26 2004-06-23 Hidtil ukendt imidazopyridinforbindelse II med terpeutisk effekt
PL04749051T PL1641793T3 (pl) 2003-06-26 2004-06-23 Nowy związek imidazopirydynowy II o działaniu leczniczym
RU2005141059/04A RU2348634C2 (ru) 2003-06-26 2004-06-23 Новое имидазопиридиновое соединение i с терапевтическим действием
CN2010102568618A CN101941968A (zh) 2003-06-26 2004-06-23 具有治疗效果的新咪唑并吡啶化合物
CA002530181A CA2530181A1 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound ii with therapeutic effect
UY28384A UY28384A1 (es) 2003-06-26 2004-06-24 Nuevo compuesto de imidazopiridina ii con efecto terapeutico
MYPI20042466A MY140718A (en) 2003-06-26 2004-06-24 Novel imidazopyridine compound ii with therapeutic effect
IL172530A IL172530A0 (en) 2003-06-26 2005-12-12 Novel imidazopyridine compound ii with therapeutic effect
ZA200510455A ZA200510455B (en) 2003-06-26 2005-12-22 Novel imidazopyridine compound II with therapeutic effect
IS8258A IS8258A (is) 2003-06-26 2006-01-23 Nýtt imídasópýridínefnasamband II með meðferðarfræðileg áhrif
NO20060425A NO20060425L (no) 2003-06-26 2006-01-26 Ny imidazopyridinforbindelse II med terapeutisk effekt
HK06108623A HK1088315A1 (en) 2003-06-26 2006-08-03 Novel imidazopyridine compound II with therapeuticeffect
HR20080179T HRP20080179T3 (en) 2003-06-26 2008-04-18 Novel imidazopyridine compound ii with therapeutic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301904A SE0301904D0 (sv) 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect

Publications (1)

Publication Number Publication Date
SE0301904D0 true SE0301904D0 (sv) 2003-06-26

Family

ID=27656637

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301904A SE0301904D0 (sv) 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect

Country Status (29)

Country Link
US (1) US7691875B2 (sv)
EP (1) EP1641793B1 (sv)
JP (1) JP4701168B2 (sv)
KR (1) KR20060030479A (sv)
CN (2) CN1809567A (sv)
AR (1) AR044855A1 (sv)
AT (1) ATE386033T1 (sv)
AU (1) AU2004249655B2 (sv)
BR (1) BRPI0411728A (sv)
CA (1) CA2530181A1 (sv)
DE (1) DE602004011773T2 (sv)
DK (1) DK1641793T3 (sv)
ES (1) ES2300796T3 (sv)
HK (1) HK1088315A1 (sv)
HR (1) HRP20080179T3 (sv)
IL (1) IL172530A0 (sv)
IS (1) IS8258A (sv)
MX (1) MXPA05013643A (sv)
MY (1) MY140718A (sv)
NO (1) NO20060425L (sv)
PL (1) PL1641793T3 (sv)
PT (1) PT1641793E (sv)
RU (1) RU2348634C2 (sv)
SE (1) SE0301904D0 (sv)
TW (1) TW200503702A (sv)
UA (1) UA81953C2 (sv)
UY (1) UY28384A1 (sv)
WO (1) WO2004113339A1 (sv)
ZA (1) ZA200510455B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007337104A1 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Imidazopyridine inhibitors of IAP
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
SE9801526D0 (sv) 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
WO2002064121A1 (en) 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
SE0102808D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
HK1088315A1 (en) 2006-11-03
US20070066642A1 (en) 2007-03-22
PL1641793T3 (pl) 2008-07-31
ATE386033T1 (de) 2008-03-15
MY140718A (en) 2010-01-15
KR20060030479A (ko) 2006-04-10
MXPA05013643A (es) 2006-02-24
EP1641793A1 (en) 2006-04-05
UY28384A1 (es) 2005-01-31
WO2004113339A1 (en) 2004-12-29
DE602004011773T2 (de) 2009-02-05
DK1641793T3 (da) 2008-05-26
RU2005141059A (ru) 2006-08-10
DE602004011773D1 (de) 2008-03-27
IS8258A (is) 2006-01-23
IL172530A0 (en) 2006-04-10
PT1641793E (pt) 2008-04-17
NO20060425L (no) 2006-03-24
CN101941968A (zh) 2011-01-12
EP1641793B1 (en) 2008-02-13
JP4701168B2 (ja) 2011-06-15
AU2004249655A1 (en) 2004-12-29
ZA200510455B (en) 2007-01-31
JP2007521266A (ja) 2007-08-02
AU2004249655B2 (en) 2008-04-17
HRP20080179T3 (en) 2008-05-31
TW200503702A (en) 2005-02-01
AR044855A1 (es) 2005-10-05
CN1809567A (zh) 2006-07-26
BRPI0411728A (pt) 2006-08-08
CA2530181A1 (en) 2004-12-29
ES2300796T3 (es) 2008-06-16
UA81953C2 (uk) 2008-02-25
US7691875B2 (en) 2010-04-06
RU2348634C2 (ru) 2009-03-10

Similar Documents

Publication Publication Date Title
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
DE60315492D1 (de) Medizinisch verwendbare arylethanolamin verbindungen
ATE381535T1 (de) Phenethanolaminderivate
RU2013121788A (ru) Ингибиторы репликации вич
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
YU65804A (sh) Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze
NO20062905L (no) Nye hydroksaminsyreestere og farmasoytisk anvendelse derav
PE20030823A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
SE9901573D0 (sv) New compounds
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
TW200606164A (en) New compounds
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
TW200800984A (en) New compounds
SE0102440D0 (sv) New compound
SE0002476D0 (sv) New compounds
MXPA05010020A (es) Derivados de oxamida.
GB0310726D0 (en) Therapeutic agents
SE9901572D0 (sv) New compounds
JP2016530208A5 (sv)
SE0201837D0 (sv) Chemical compounds